TVRD

Tvardi Therapeutics, Inc. - Common Stock (TVRD)

About Tvardi Therapeutics, Inc. - Common Stock (TVRD)

Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.

Details

Daily high
$1.17
Daily low
$1.06
Price at open
$1.17
52 Week High
$5.69
52 Week Low
$0.77
Market cap
15.7M
Dividend yield
-
Volume
64,369
Avg. volume
378,995
P/E ratio
-.42

Tvardi Therapeutics, Inc. - Common Stock News

Details

Daily high
$1.17
Daily low
$1.06
Price at open
$1.17
52 Week High
$5.69
52 Week Low
$0.77
Market cap
15.7M
Dividend yield
-
Volume
64,369
Avg. volume
378,995
P/E ratio
-.42